Medical devices, healthcare technology and the business of care
510(k) clearance · K262243

Profisil Free

Kettenbach GmbH & Co. KG · Decision date Sep 3, 2026

MEDTECHLEDGER EXPLANATIONK262243

What did the FDA decide?

FDA recorded a substantial-equivalence decision (SESE) for Profisil Free, a cavity varnish from Kettenbach GmbH & Co. KG, dated September 3, 2026, under 21 CFR 872.3260, Class II, product code LBH, in the Dental specialty. The submission, K262243, was dated and received July 1, 2026. The device is described as a fluoride-free varnish intended to produce mechanical occlusion of dentinal tubules in treating tooth hypersensitivity, supplied in single-dose 0.5 mL blisters with an applicator brush.

The listed predicate is ReminGel (Inter-Med, Inc. / Vista Apex), K241489. The summary states the intended purpose, indication, patient population, mechanism of action and principle of operation are the same in substance, while the formulation base and delivery system differ; it concludes the packaging difference does not affect the equivalence determination. Biocompatibility testing under cited ISO 10993 parts is reported. The provided excerpts do not include the full contraindications text, shelf-life data or the complete performance results.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Dental
Decision date
Sep 3, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262243
Regulatory pathway
510(k) premarket notification
Product code
LBH
Decision code
SESE
Decision date
Sep 3, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Varnish, Cavity.

Product code
LBH
FDA device class
2

FDA decision timeline

  1. K262243 received

    Application receipt date recorded by FDA.

  2. K262243 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code LBH

Product / regulatory recordCompanyPathwayDecision dateSource
The Belport Company Inc., DBA Gingi-Pak510(k) clearanceOct 27, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kettenbach GmbH & Co. KG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Eschenburg

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records